Table 2

PCR primers

NameSenseAntisense
KIR2DL3 mRNA CCACTGAACCAAGCTCCG CAGGAGACAACTTTGGATCA 
β-actin ATGGCCACGGCTGCTTCCAGC CATGGTGGTGCCGCCAGACAG 
Methylation-specific primers   
KIR2DL3   
    1st round TTATTTTGATGTTTTTGGTTTAGTAG CCTATATCTCCAACTCTAAACC 
    2nd round CGTGTATGAGAGGTTGGATTTGAG CCTTCCAAAACTCACCAAC 
    CpG −170/−160 TATGTTTCGTTTTTGAGC (M)TATGTTTTGTTTTTGAGT (U) TTCCAAAACTCACCAACACA (M and U) 
    CpG −120/−116 TAGAAAGAGTTTGCGTAC (M)TAGAAAGAGTTTGTGTAT (U) TTCCAAAACTCACCAACACA (M and U) 
    CpG −50 GGTTTTATGTAAGGTAGAAAGAGT (M and U) AACTCAACTCAACAACG (M)AACTCAACTCAACAACA (U) 
    CpG −27/−23 GGTTTTATGTAAGGTAGAAAGAGT (M and U) ATACAAACAAACGACCG (M)ATACAAACAAACAACCA (U) 
ChIP   
    KIR2DL3 (−96 to +11) GGTCAACATGTAAACTGCATG ATGAGCGACATGGTGCTGTCT 
    CD70 (−481 to −395) GCTCAGACAGGAGAATCGCTTG TCTGTCACCCAGGCTGGAGT 
    CD11a (−1206 to −1101) AACTCTTGACCTCAGGTGATC ACTGGTTGTGCTCCATTAGT 
NameSenseAntisense
KIR2DL3 mRNA CCACTGAACCAAGCTCCG CAGGAGACAACTTTGGATCA 
β-actin ATGGCCACGGCTGCTTCCAGC CATGGTGGTGCCGCCAGACAG 
Methylation-specific primers   
KIR2DL3   
    1st round TTATTTTGATGTTTTTGGTTTAGTAG CCTATATCTCCAACTCTAAACC 
    2nd round CGTGTATGAGAGGTTGGATTTGAG CCTTCCAAAACTCACCAAC 
    CpG −170/−160 TATGTTTCGTTTTTGAGC (M)TATGTTTTGTTTTTGAGT (U) TTCCAAAACTCACCAACACA (M and U) 
    CpG −120/−116 TAGAAAGAGTTTGCGTAC (M)TAGAAAGAGTTTGTGTAT (U) TTCCAAAACTCACCAACACA (M and U) 
    CpG −50 GGTTTTATGTAAGGTAGAAAGAGT (M and U) AACTCAACTCAACAACG (M)AACTCAACTCAACAACA (U) 
    CpG −27/−23 GGTTTTATGTAAGGTAGAAAGAGT (M and U) ATACAAACAAACGACCG (M)ATACAAACAAACAACCA (U) 
ChIP   
    KIR2DL3 (−96 to +11) GGTCAACATGTAAACTGCATG ATGAGCGACATGGTGCTGTCT 
    CD70 (−481 to −395) GCTCAGACAGGAGAATCGCTTG TCTGTCACCCAGGCTGGAGT 
    CD11a (−1206 to −1101) AACTCTTGACCTCAGGTGATC ACTGGTTGTGCTCCATTAGT 

M indicates methylated; and U, unmethylated.

or Create an Account

Close Modal
Close Modal